NDC00093-0311-01: LOPERAMIDE HYDROCHLORIDE CAPSULE.
LOPERAMIDE HYDROCHLORIDE CAPSULE. Key specifications include primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 2.000 MILLIGRAMS LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: LOPERAMIDE HYDROCHLORIDE CAPSULES USP 2MG 100S BT, capsule_primary_container_content_quantity: 100.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-066-6568, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 2.000 MILLIGRAMS LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LOPERAMIDE HYDROCHLORIDE CAPSULES USP 2MG 100S BT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-066-6568 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LOPERAMIDE HYDROCHLORIDE CAPSULES USP 2MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 MILLIGRAMS LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.